Quick Takeaways
- Octagon Capital Advisors LP filed SCHEDULE 13G for Taysha Gene Therapies, Inc. Common Stock, $0.00001 par value (TSHA).
- Disclosed ownership: 5.1%.
- Date of event: 31 Dec 2024.
Octagon Capital Advisors LP - 31 Dec 2024 SCHEDULE 13G Report for Taysha Gene Therapies, Inc. Common Stock, $0.00001 par value (TSHA)
- Filing Manager
- Octagon Capital Advisors LP
- Reporting Manager
- Octagon Capital Advisors LP
- Symbol
- TSHA
- Shares outstanding
- 204,901,961 shares
- Disclosed Ownership
- 10,450,000 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G
- Filing time
- 05 Feb 2025, 18:05:13 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Octagon Capital Advisors LP disclosed 5.1% ownership in Taysha Gene Therapies, Inc. Common Stock, $0.00001 par value (TSHA) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Feb 2025, 18:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Octagon Capital Advisors LP | 5.1% | 10,450,000 | 0 | 10,450,000 | /s/ Ting Jia | Managing Member | |
| Octagon Investments Master Fund | 5.1% | 10,450,000 | 0 | 10,450,000 | /s/ Ting Jia | Managing Member, Octagon Investments GP, LLC, its general partner | |
| Ting Jia | 5.1% | 10,450,000 | 0 | 10,450,000 | /s/ Ting Jia | Ting Jia |